← Leaderboards
Bridgette Michelle Collins-Burow
Tulane University Of Louisiana
$1,920,948
Attributed
$1,920,948
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $399.7K · FY2009–20$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,920,948 · 3
By mechanism
R01$1,806,603 · 1
P20$114,345 · 2
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Frank E Jones$5,175,445
- Tomoo Iwakuma$5,211,581
- Hua Lu$18,463,532
- Steven M Hill$2,241,696
- Tamika T Duplessis$55,010
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseClinical TrialsNew Therapeutic TargetTumorigenesisPhenotypeIn VitroGene ExpressionNeoplasm MetastasisSignal TransductionTriple-Negative Invasive Breast CarcinomaCellsTranslatingBreast Cancer CellIn VivoBiological ModelsEpithelial To Mesenchymal TransitionBiological Adaptation To StressErbb2 GeneE-CadherinCell TypeEstrogen ReceptorsFutureCell PolarityBreast Cancer Cell Line
Grant awards (8)
Kinase mediated suppression of metastasis in breast cancer$374,108
R01 · FY2020 · CA · contact PI
Kinase mediated suppression of metastasis in breast cancer$333,940
R01 · FY2019 · CA · contact PI
Kinase mediated suppression of metastasis in breast cancer$65,748
R01 · FY2019 · CA · contact PI
Kinase mediated suppression of metastasis in breast cancer$344,269
R01 · FY2018 · CA · contact PI
Kinase mediated suppression of metastasis in breast cancer$344,269
R01 · FY2017 · CA · contact PI
Kinase mediated suppression of metastasis in breast cancer$344,269
R01 · FY2016 · CA · contact PI
GLYCEOLLINS AS NOVEL TARGETED THERAPEUTICS FOR THE TREATMENT OF METASTATIC TRIPL$28,404
P20 · FY2011 · RR · contact PI
GLYCEOLLINS AS NOVEL TARGETED THERAPEUTICS FOR THE TREATMENT OF METASTATIC TRIPL$85,941
P20 · FY2009 · RR · contact PI